Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties - Non-oncology Endocrinology/Neuroendocrine

SUV on somatostatin receptor (SSTR) PET/CT imaging as a biomarker for glucose metabolism related pancreatic function

Sophie Kunte, Thorsten Siegmund, Adrien Holzgreve, Gabriel Sheikh, Peter Bartenstein and Lena Unterrainer
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P832;
Sophie Kunte
1Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thorsten Siegmund
2Division for Endocrinology, Diabetology and Metabolism, Isar Clinic Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrien Holzgreve
3Department of Nuclear Medicine, University Hospital, LMU Munich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriel Sheikh
1Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Bartenstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lena Unterrainer
4Department of Nuclear Medicine, LMU Munich and Department of Nuclear Medicine, UCLA, Los Angeles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 64 no. supplement 1 P832

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 28, 2023.

Copyright & Usage 
© 2023

Author Information

  1. Sophie Kunte1,
  2. Thorsten Siegmund2,
  3. Adrien Holzgreve3,
  4. Gabriel Sheikh1,
  5. Peter Bartenstein and
  6. Lena Unterrainer4
  1. 1Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany
  2. 2Division for Endocrinology, Diabetology and Metabolism, Isar Clinic Munich, Munich, Germany
  3. 3Department of Nuclear Medicine, University Hospital, LMU Munich
  4. 4Department of Nuclear Medicine, LMU Munich and Department of Nuclear Medicine, UCLA, Los Angeles

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: August 2023 to April 2025

AbstractFullPdf
Aug 2023200
Sep 20232300
Oct 20231600
Nov 20232100
Dec 20231300
Jan 20241200
Feb 2024900
Mar 20241300
Apr 20244100
May 20241900
Jun 20243400
Jul 20249000
Aug 20247600
Sep 20242800
Oct 20241900
Nov 20241100
Dec 2024700
Jan 20251100
Feb 20251600
Mar 20251400
Apr 20252100
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
SUV on somatostatin receptor (SSTR) PET/CT imaging as a biomarker for glucose metabolism related pancreatic function
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
SUV on somatostatin receptor (SSTR) PET/CT imaging as a biomarker for glucose metabolism related pancreatic function
Sophie Kunte, Thorsten Siegmund, Adrien Holzgreve, Gabriel Sheikh, Peter Bartenstein, Lena Unterrainer
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P832;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
SUV on somatostatin receptor (SSTR) PET/CT imaging as a biomarker for glucose metabolism related pancreatic function
Sophie Kunte, Thorsten Siegmund, Adrien Holzgreve, Gabriel Sheikh, Peter Bartenstein, Lena Unterrainer
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P832;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Usefulness of 4D SPECT/CT 99mTc-sestamibi imaging in patients with primary hyperparathyroidism
  • The Value of 68Ga-DOTATATE PET/CT in Assessing the Inflammatory Activity of Extraocular Muscles in Thyroid Associated Orbitopathy
  • 18F-ALF-NOTA-pentixather PET/CT targeting CXCR4 in patients with suspected primary hyperaldosteronism
Show more General Clinical Specialties - Non-oncology Endocrinology/Neuroendocrine

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire